HopeStage
Back to all studies
Active Not RecruitingNCT05819021

Five-day accelerated TMS for depression: treatment optimization

About this titleRead the official source — NCT05819021
Observational studyAges 18+United States
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
Costa Mesa and 6 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 6, 2023
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
1,000
Sponsor
Magnus Medical
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Device
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT05819021
Official title
Show the full official title

An Open Label Optimization Study to Assess the Effectiveness of the SAINT® Neuromodulation System (NMS) to Treat Major Depressive Disorder

Recruitment & locations

Not recruiting

Costa Mesa · Los Angeles · Sunnyvale

3 more locations
  • Natick
  • Brooklyn
  • Seattle

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Magnus Medical.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies